Does desloratadine alter the serum levels of montelukast when administered in a fixed‐dose combination?
- 5 August 2013
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 123 (11) , 2610-2614
Abstract
Objectives/Hypothesis The aim of this study was to investigate the serum levels of montelukast when administered alone or in combination with desloratadine. Study Design A prospective crossover study. Methods Twenty-three healthy volunteers were investigated in two sessions. Volunteers were given 10 mg of montelukast orally with 250 mL water in the first session. The same subjects were given 10 mg of montelukast in fixed combination with 5 mg desloratadine 10 days after first session. Blood samples were collected 2, 3, and 4 hours after drug administration, and kept at −80°C after both applications. Plasma samples were analyzed for montelukast concentration. Results Mean concentration values of both groups were not statistically different (P > .05), but the differences were statistically significant according to time (P < .05). Statistically significant difference was not found between the groups according to the area under curve on the basis of both marginal and cumulative values for all different time intervals (P > .05). Conclusions The absorption rate of montelukast was not altered when administered with desloratadine. This study suggested that desloratadine does not influence the bioavailability of montelukast, and their combination therapy can be used safely. Level of Evidence 2b Laryngoscope, 123:2610–2614, 2013Keywords
This publication has 22 references indexed in Scilit:
- Loratadine and Montelukast Administered in Combination Produce Decongestion in an Experimental Feline Model of Nasal CongestionAmerican Journal of Rhinology & Allergy, 2009
- Medicinal importance of grapefruit juice and its interaction with various drugsNutrition Journal, 2007
- Montelukast in the Treatment of Allergic RhinitisDrugs, 2007
- Effect of combined montelukast and desloratadine on the early asthmatic response to inhaled allergenJournal of Allergy and Clinical Immunology, 2005
- Second-Generation AntihistaminesDrugs, 2005
- Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double‐blind, placebo‐controlled studyClinical & Experimental Allergy, 2004
- The ARIA/EAACI criteria for antihistamines: an assessment of the efficacy, safety and pharmacology of desloratadineAllergy, 2004
- DesloratadineDrugs, 2003
- Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestionAnnals of Allergy, Asthma & Immunology, 2002
- Antihistamines alone and in combination with leukotriene antagonists in nasal congestionClinical & Experimental Allergy Reviews, 2002